
Inogen INGN
$ 6.8
1.87%
Quarterly report 2025-Q3
added 11-06-2025
Inogen Interest Expense 2011-2025 | INGN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Inogen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 850 K | 468 K | -862 K | -710 K | 5.84 M | -229 K | -696 K | 1.3 M | 6 K | 22 K | 449 K | 562 K | 493 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.84 M | -862 K | 576 K |
Quarterly Interest Expense Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 606 K | 701 K | 356 K | - | 687 K | 134 K | 143 K | - | -398 K | 337 K | 237 K | - | -12 K | -722 K | -433 K | - | -466 K | 304 K | -310 K | - | -54 K | 5.7 M | -60 K | - | -503 K | 145 K | -120 K | - | 8 K | -1.05 M | 444 K | - | 264 K | 523 K | 207 K | - | 1 K | 2 K | 3 K | - | 5 K | 6 K | 7 K | - | 104 K | 203 K | 133 K | - | 113 K | 95 K | 104 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.7 M | -1.05 M | 191 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.47 | -3.61 % | $ 120 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 96.06 | -0.04 % | $ 141 B | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.35 | -1.99 % | $ 671 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 303.76 | 0.52 % | $ 8.57 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 47.89 | -0.48 % | $ 7.14 K | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 124.72 | -0.1 % | $ 217 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.3 | 11.09 % | $ 123 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.92 | -0.25 % | $ 3.41 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 158.62 | 0.49 % | $ 11.9 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.83 | -3.49 % | $ 85.3 M | ||
|
LENSAR
LNSR
|
660 K | $ 12.03 | 0.17 % | $ 139 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.53 | 0.48 % | $ 1.24 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 14.04 | -3.13 % | $ 379 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.51 | -0.13 % | $ 95.1 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.87 | 0.7 % | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.89 | 2.12 % | $ 1.26 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.36 | -0.29 % | $ 401 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 88.38 | -0.15 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.65 | -0.08 % | $ 974 M | ||
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.58 | 3.61 % | $ 4.03 M | ||
|
Myomo
MYO
|
21.1 K | $ 1.02 | - | $ 7.19 M |